These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15657617)

  • 1. Cascade testing in familial hypercholesterolaemia: how should family members be contacted?
    Newson AJ; Humphries SE
    Eur J Hum Genet; 2005 Apr; 13(4):401-8. PubMed ID: 15657617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees' views.
    van Maarle MC; Stouthard ME; Marang-van de Mheen PJ; Klazinga NS; Bonsel GJ
    Community Genet; 2001; 4(4):244-52. PubMed ID: 12751487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attitude to genetic screening for familial hypercholesterolemia].
    Ose L; Vollebaek LE; Tonstad S
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1578-81. PubMed ID: 9615587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A family-based strategy for diagnosing familial hypercholesterolemia].
    Leren TP; Manshaus T; Ose L
    Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Information for family members with an increased risk for a genetic disease].
    Gordijn B
    Dtsch Med Wochenschr; 2006 Mar; 131(11):573-6. PubMed ID: 16538564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of cascade testing for the detection of familial hypercholesterolaemia.
    Hadfield SG; Humphries SE
    Curr Opin Lipidol; 2005 Aug; 16(4):428-33. PubMed ID: 15990592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: a summary of the evidence.
    Allison M
    J Cardiovasc Nurs; 2015; 30(4):E1-E12. PubMed ID: 24831729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre.
    Gray J; Jaiyeola A; Whiting M; Modell M; Wierzbicki AS
    Heart; 2008 Jun; 94(6):754-8. PubMed ID: 17575326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beyond the diagnosis of a genetic disease, the question of informing the relatives].
    Pellerin P
    Ann Pharm Fr; 2009 Jan; 67(1):20-4. PubMed ID: 19152847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade screening: whose information is it anyway?
    de Wert G
    Eur J Hum Genet; 2005 Apr; 13(4):397-8. PubMed ID: 15702129
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confidentiality and serious harm in genetics - preserving the confidentiality of one patient and preventing harm to relatives.
    Lucassen A; Parker M
    Eur J Hum Genet; 2004 Feb; 12(2):93-7. PubMed ID: 14673475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic screening of patients with familial hypercholesterolemia and insurability for life insurance policies and disability cover policies].
    Homsma SJ; Lansberg PJ; Kastelein JJ
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):493-6. PubMed ID: 15042898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No certain predictors for mutation status in a Danish cohort with familial hypercholesterolemia: a descriptive study.
    Nybo M; Brusgaard K; Hansen AB
    Clin Biochem; 2007 Dec; 40(18):1347-52. PubMed ID: 17961529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.